American Diabetes Association updates recommendations regarding SGLT-2 inhibitors, GLP-1 RA, and finerenone for cardiovascular and renal comorbidities.
Jana Kay Lacanlale, PharmD Candidate
Advertisement
Articles by Jana Kay Lacanlale, PharmD Candidate
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Fall 2025 Quiz: Test Your Pharmacy Knowledge!
2
FDA Approves Elinzanetant as First Nonhormonal Therapy for Menopause Vasomotor Symptoms
3
Lynkuet Access Program Aims to Help Women Save on Neurokinin-Targeted Therapy
4
Disparities in Continuous Glucose Monitor Prescriptions by Language Preference Among Adults With Type 2 Diabetes
5
